Flywheel Achieves Major Growth and Leverages New Products for Clinical Trials

Flywheel's Remarkable Growth in Medical Imaging and Data Management

In a significant milestone for the medical imaging sector, Flywheel, a prominent platform specializing in imaging data management and analysis, recently reported record advancements in 2025. The company has not only expanded its operational footprint but also introduced innovative products to bolster its offerings in clinical trials and medical device markets. With their recent closure of a $27.5 million equity round, Flywheel is well-positioned to accelerate further growth and development.

Strategic Milestones Achieved

Founded with the intent of providing a reliable technology infrastructure for core lab research, Flywheel has successfully pivoted to become a comprehensive enterprise imaging management platform. This evolution reflects a broader trend within the healthcare sector, where imaging data is increasingly recognized as an essential strategic asset. Flywheel’s solutions support clinical trials, medical device development, and advancements in artificial intelligence (AI) by streamlining data aggregation, curation, and analysis processes.

The latest addition, Flywheel Validated, is designed to enhance workflows compliant with the Code of Federal Regulations, specifically 21 CFR Part 11, which governs electronic records and signatures for clinical trials. This innovative solution empowers clinical trial stakeholders to access and analyze imaging data more efficiently, expediting decision-making processes – a critical factor in accelerating the time to market for new medical products.

Impressive Client Base and Platform Adoption

The company has garnered the trust of significant players in the pharmaceutical and medical sectors. Notably, 10 of the top 20 global pharmaceutical companies have chosen Flywheel to advance their digital transformation strategies. Moreover, their user base now includes several of the leading academic medical centers, allowing Flywheel to extend its capabilities not only to research sponsors but also to medical device developers.

The financial growth speaks for itself, with Flywheel witnessing a staggering 43% year-over-year growth in new business, complemented by a 40% increase in committed revenue. The annual recurring revenue (ARR) from customers within pharmaceuticals and medical device industries surged by 106% compared to the previous year, ensuring robust loyalty and retention across key market segments.

Novel Product Innovations

Throughout 2025, Flywheel has launched several new products aimed at enhancing functionality and user experience. Among these, their innovative video viewing and annotation tool allows for the management and analysis of video data in conjunction with imaging data. This feature is especially beneficial in clinical settings where video data, alongside imaging, provides a richer context for analysis.

The introduction of Flywheel Validated has been a game-changer for stakeholders in the clinical trial ecosystem, bridging gaps in accessing and analyzing clinical imaging data while ensuring compliance with regulatory standards. This array of tools not only enhances the efficiency of clinical trials but also strengthens secondary data use in a compliant environment, ultimately fostering an ecosystem of informed decision-making.

Future Outlook and Investment

The recent capital infusion of $27.5 million will further catalyze Flywheel's commitment to product development and innovation, particularly in image management tailored for clinical trials and AI model enhancement. The backing from prominent investors like Novalis Life Sciences LLC and 8VC reinforces the confidence in Flywheel’s growth trajectory and the transformative potential they offer within the healthcare space.

As healthcare increasingly emphasizes the value of imaging data, Flywheel is positioned as a critical enabler, transforming how healthcare entities leverage imaging assets for better outcomes. Hooman Hakami, CEO and Board Chair, emphasizes, "Unlocking the value of imaging data involves integrated data management, curation, and AI capabilities, which are essential for navigating today’s healthcare complexities."

For those interested in learning more about Flywheel and exploring its offerings, detailed information is available at Flywheel's website.

As Flywheel continues its upward trajectory, the healthcare industry will benefit significantly from its innovations that improve research workflow, enhance data management, and ultimately lead to better health solutions.